• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿来替尼用于ALK阳性肺腺癌的粟粒性肺转移

Alectinib for Miliary Lung Metastasis in -Positive Lung Adenocarcinoma.

作者信息

Satoh Hironori, Okuma Yusuke, Kashima Jumpei, Konnno-Yamamoto Aya, Yatabe Yasushi, Ohe Yuichiro

机构信息

Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.

Department of Pathology, National Cancer Center Hospital, Tokyo, Japan.

出版信息

Onco Targets Ther. 2021 Apr 30;14:2911-2915. doi: 10.2147/OTT.S300229. eCollection 2021.

DOI:10.2147/OTT.S300229
PMID:33958877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8096437/
Abstract

BACKGROUND

Miliary pulmonary metastasis characterized by tiny nodules is a rare metastatic pattern in advanced non-small cell lung cancer (NSCLC) and is usually seen in patients harboring an mutation, and amylase-producing lung cancer is highly uncommon and rarely reported in NSCLC patients who have an mutation.

CASE

A 32-year-old Japanese female was found to have miliary pulmonary nodules throughout both lung fields on a chest x-ray examination during an annual health check-up. Further examination by computed tomography (CT) revealed diffuse, bilateral, miliary nodules. Blood tests showed no increased tumor marker levels, but there was a significantly increased serum amylase level. A diagnosis of -rearranged adenocarcinoma was made based on the results of a mediastinal lymph node biopsy obtained by endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). Treatment with alectinib resulted in rapid regression of the CT shadows and a reduction in the patient's serum amylase level.

CONCLUSION

We have reported a case of -rearranged NSCLC with a miliary pulmonary metastasis pattern that was sensitive to alectinib and in which the serum amylase level decreased in response to treatment with alectinib. Young patients with miliary pulmonary metastasis should be checked for all driver mutations.

摘要

背景

以微小粟粒结节为特征的粟粒性肺转移是晚期非小细胞肺癌(NSCLC)中一种罕见的转移模式,通常见于携带某种突变的患者,而产生淀粉酶的肺癌极为罕见,在携带该突变的NSCLC患者中鲜有报道。

病例

一名32岁日本女性在年度健康检查的胸部X光检查中发现双肺野布满粟粒性肺结节。计算机断层扫描(CT)进一步检查显示双侧弥漫性粟粒结节。血液检查显示肿瘤标志物水平未升高,但血清淀粉酶水平显著升高。根据经支气管超声引导下经支气管针吸活检(EBUS-TBNA)获取的纵隔淋巴结活检结果,诊断为某种重排腺癌。使用阿来替尼治疗导致CT阴影迅速消退,患者血清淀粉酶水平降低。

结论

我们报告了一例具有粟粒性肺转移模式的某种重排NSCLC病例,该病例对阿来替尼敏感,且使用阿来替尼治疗后血清淀粉酶水平下降。对于有粟粒性肺转移的年轻患者,应检查所有驱动基因突变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e564/8096437/dbaae08c3b0d/OTT-14-2911-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e564/8096437/800aa6ff777e/OTT-14-2911-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e564/8096437/dbaae08c3b0d/OTT-14-2911-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e564/8096437/800aa6ff777e/OTT-14-2911-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e564/8096437/dbaae08c3b0d/OTT-14-2911-g0002.jpg

相似文献

1
Alectinib for Miliary Lung Metastasis in -Positive Lung Adenocarcinoma.阿来替尼用于ALK阳性肺腺癌的粟粒性肺转移
Onco Targets Ther. 2021 Apr 30;14:2911-2915. doi: 10.2147/OTT.S300229. eCollection 2021.
2
Major pathologic response to alectinib in ALK-rearranged adenocarcinoma of the lung.在ALK重排的肺腺癌中对阿来替尼的主要病理反应。
Surg Case Rep. 2018 Mar 9;4(1):19. doi: 10.1186/s40792-018-0430-7.
3
[Lung Adenocarcinomas with Pulmonary Miliary Metastases: A Case Report and Literature Review].[伴有肺粟粒样转移的肺腺癌:1例报告及文献复习]
Zhongguo Fei Ai Za Zhi. 2019 Dec 20;22(12):798-804. doi: 10.3779/j.issn.1009-3419.2019.12.11.
4
Feasibility and Safety of Neoadjuvant Alectinib in Pulmonary Invasive Mucinous Adenocarcinoma with ALK Rearrangement: Case Report and Literature Review.新辅助阿来替尼治疗ALK重排的肺浸润性黏液腺癌的可行性和安全性:病例报告及文献综述
Onco Targets Ther. 2021 Oct 21;14:5107-5113. doi: 10.2147/OTT.S334213. eCollection 2021.
5
Application of endobronchial ultrasound-guided transbronchial needle aspiration following integrated PET/CT in mediastinal staging of potentially operable non-small cell lung cancer.在综合PET/CT检查后,应用支气管内超声引导下经支气管针吸活检术对潜在可切除的非小细胞肺癌进行纵隔分期。
Chest. 2009 May;135(5):1280-1287. doi: 10.1378/chest.08-2019. Epub 2008 Dec 31.
6
The evaluation of lymph node metastasis by endobronchial ultrasound-guided transbronchial needle aspiration: crucial for selection of surgical candidates with metastatic lung tumors.经支气管超声引导下经支气管针吸活检术对淋巴结转移的评估:对转移性肺肿瘤手术候选者的选择至关重要。
J Thorac Cardiovasc Surg. 2007 Dec;134(6):1485-90. doi: 10.1016/j.jtcvs.2007.07.022.
7
Efficacy of convex probe endobronchial ultrasound (CP-EBUS) assisted transbronchial needle aspiration for mediastinal staging in non-small cell lung cancer cases with mediastinal lymphadenopathy.凸阵探头支气管内超声(CP-EBUS)辅助经支气管针吸活检在伴有纵隔淋巴结肿大的非小细胞肺癌纵隔分期中的疗效
Ann Thorac Cardiovasc Surg. 2011;17(3):236-42. doi: 10.5761/atcs.oa.10.01659.
8
Relationship between endobronchial ultrasound-guided (EBUS)-transbronchial needle aspiration utility and computed tomography staging, node size at EBUS, and positron emission tomography scan node standard uptake values: A retrospective analysis.经支气管超声引导(EBUS)-经支气管针吸术的应用与计算机断层扫描分期、EBUS 时的淋巴结大小和正电子发射断层扫描(PET)扫描淋巴结标准摄取值之间的关系:一项回顾性分析。
Thorac Cancer. 2017 Jul;8(4):285-290. doi: 10.1111/1759-7714.12438. Epub 2017 Apr 24.
9
ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literature.对阿来替尼有反应的ALK重排肺鳞状细胞癌:一例报告并文献复习
BMC Cancer. 2017 Jul 6;17(1):471. doi: 10.1186/s12885-017-3468-1.
10
EML4-ALK fusion gene assessment using metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration.采用经支气管超声引导经支气管针吸活检术获取的转移性淋巴结样本进行 EML4-ALK 融合基因检测。
Clin Cancer Res. 2010 Oct 15;16(20):4938-45. doi: 10.1158/1078-0432.CCR-10-0099. Epub 2010 Oct 5.

引用本文的文献

1
Case Report: Recombinant Human Endostatin Plus Chemotherapy for Epidermal Growth Factor Receptor-Negative Miliary Lung Adenocarcinoma.病例报告:重组人内皮抑素联合化疗治疗表皮生长因子受体阴性粟粒型肺腺癌
Front Oncol. 2022 Jul 4;12:922076. doi: 10.3389/fonc.2022.922076. eCollection 2022.

本文引用的文献

1
Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with Rearrangement.免疫检查点抑制剂单药治疗伴有重排的晚期非小细胞肺癌的疗效。
Int J Mol Sci. 2020 Apr 9;21(7):2623. doi: 10.3390/ijms21072623.
2
Adenocarcinoma of the Lung Mimicking Miliary Tuberculosis.酷似粟粒性肺结核的肺腺癌
Case Rep Oncol. 2020 Feb 13;13(1):139-144. doi: 10.1159/000505685. eCollection 2020 Jan-Apr.
3
Survival analysis and pathological features of advanced non-small cell lung cancer with miliary pulmonary metastases in patients harboring epidermal growth factor receptor mutations.
表皮生长因子受体突变的广泛肺转移的晚期非小细胞肺癌的生存分析及病理特征。
J Cancer Res Clin Oncol. 2018 Aug;144(8):1601-1611. doi: 10.1007/s00432-018-2681-x. Epub 2018 Jun 1.
4
Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non-Small-Cell Lung Cancer.一线克唑替尼对比化疗用于 ALK 基因突变阳性非小细胞肺癌的研究的最终总生存分析。
J Clin Oncol. 2018 Aug 1;36(22):2251-2258. doi: 10.1200/JCO.2017.77.4794. Epub 2018 May 16.
5
Miliary Nodules: Not Always Tuberculosis.粟粒样结节:并非总是肺结核。
Ann Am Thorac Soc. 2017 Dec;14(12):1858-1860. doi: 10.1513/AnnalsATS.201706-436CC.
6
Amylase-Producing Lung Cancer with a Positive Epidermal Growth Factor Receptor Mutation Treated With Gefitinib: A Case Report.吉非替尼治疗伴有表皮生长因子受体突变阳性的产淀粉酶肺癌:一例报告
World J Oncol. 2014 Feb;5(1):41-46. doi: 10.14740/wjon778w. Epub 2014 Mar 11.
7
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.利用肺癌致癌驱动基因的多重分析来选择靶向药物。
JAMA. 2014 May 21;311(19):1998-2006. doi: 10.1001/jama.2014.3741.
8
Adenocarcinoma of the lung with miliary brain and pulmonary metastases with echinoderm microtubule-associated protein like 4-anaplastic lymphoma kinase translocation treated with crizotinib: a case report.肺腺癌伴脑粟粒状和肺转移,伴棘皮动物微管相关蛋白样 4-间变性淋巴瘤激酶易位,用克唑替尼治疗:一例报告。
Lung Cancer. 2012 Dec;78(3):282-4. doi: 10.1016/j.lungcan.2012.08.015. Epub 2012 Sep 19.
9
Association of diffuse, random pulmonary metastases, including miliary metastases, with epidermal growth factor receptor mutations in lung adenocarcinoma.肺腺癌中弥漫性、随机性肺转移,包括粟粒性转移,与表皮生长因子受体突变相关。
Cancer. 2011 Feb 15;117(4):819-25. doi: 10.1002/cncr.25618. Epub 2010 Sep 30.
10
Good response to gefitinib for lung adenocarcinoma with hyperamylasemia: a case report.吉非替尼对伴高淀粉酶血症的肺腺癌疗效良好:一例报告
Chang Gung Med J. 2008 Nov-Dec;31(6):606-11.